Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7544103 | 0.90 | RAB9A (0.31) | SMN1; SMN2RAB9ALMNA | |
| SCHEMBL8123433 | 0.84 | RAB9A (0.33) | SMN1; SMN2RAB9ALMNAALDH1A1GAA | |
| SCHEMBL8871127 | 0.83 | POLB (0.32) | SMN1; SMN2RAB9ALMNAALDH1A1GAA | |
| SCHEMBL8871124 | 0.83 | POLB (0.32) | SMN1; SMN2RAB9ALMNAALDH1A1GAA | |
| SCHEMBL8120118 | 0.82 | RAB9A (0.36) | SMN1; SMN2RAB9AALDH1A1HTTCYP1A2 | |
| SCHEMBL8135089 | 0.82 | RAB9A (0.34) | SMN1; SMN2RAB9ALMNAALDH1A1CYP1A2 | |
| SCHEMBL8139294 | 0.81 | VHL (0.40) | SMN1; SMN2RAB9ALMNAALDH1A1GAA | |
| SCHEMBL7684133 | 0.78 | SMN1; SMN2 (0.33) | SMN1; SMN2RAB9ALMNAALDH1A1GAA | |
| SCHEMBL27524777 | 0.74 | LMNA (0.44) | SMN1; SMN2RAB9ALMNAALDH1A1GAA | |
| SCHEMBL7685463 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6465395-B2 | DIHYDROBENZOTHIOPHENE-SUBSTITUTED METHYLENE; CONTROL OF A BROAD SPECTRUM OF UNDESIRABLE PLANT SPECIES. | BASF AKTIENGESELLSCHAFT (DE) | 2002-10-15 | — | — | US | disclosed |
| US-20020016261-A1 | Substituted methylene pyrazolinones and the herbicidal use thereof | BASF AKTIENGESELLSCHAFT (DE) | 2002-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020016261-A1 | Substituted methylene pyrazolinones and the herbicidal use thereof | DDT, DHFR, TPMT | SMN1; SMN2 4153/4885RAB9A 3405/4885LMNA 4370/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.